The Santa Rosa Memorial Hospital CCOP is the product of five years of intensive development by a core group of oncologists who serve all of the patients in our relatively isolated four county area of California. With more than 600 inpatient visits each year, and more than 2000 new patient consultations, the nine medical oncologists who are central to this application have virtually 100% of the cancer patient market in our region. With a decade long interest in developing a competitive CCOP, our program has gradually and systematically assembled the necessary resources: data management staff, access to cooperative group clinical trials, access to cancer control trials, hospital resource commitments, the interest and involvement of non-oncology specialists and a track record of accrual success and high quality control. This application notes our current track record of success (99 patients entered on clinical trials within the last year) and our commitment to enter 125 on clinical trials during the first year of formal funding. It also notes the extraordinary lengths to which this program has gone to secure cancer control trials and the progress that we have made to date. Of significance is the access to minority populations within the region and the virtual absence of any other oncology caregivers in the area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA063850-02
Application #
2105971
Study Section
Special Emphasis Panel (SRC (74))
Project Start
1994-08-26
Project End
1997-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Santa Rosa Memorial Hospital
Department
Type
DUNS #
City
Santa Rosa
State
CA
Country
United States
Zip Code
95403
Heinrich, Michael C; Rankin, Cathryn; Blanke, Charles D et al. (2017) Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. JAMA Oncol 3:944-952
Wozniak, Antoinette J; Moon, James; Thomas Jr, Charles R et al. (2015) A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer 16:340-7
Erba, Harry P; Othus, Megan; Walter, Roland B et al. (2014) Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432. Leuk Res 38:329-33
Mehta, Rita S; Barlow, William E; Albain, Kathy S et al. (2012) Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med 367:435-44
Tomblyn, Michael B; Goldman, Bryan H; Thomas Jr, Charles R et al. (2012) Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). J Thorac Oncol 7:906-12
Marshall, James R; Tangen, Catherine M; Sakr, Wael A et al. (2011) Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 4:1761-9
Chu, David Z J; Hussey, Michael A; Alberts, David S et al. (2011) Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions. Clin Colorectal Cancer 10:310-6
Herbst, Roy S; Kelly, Karen; Chansky, Kari et al. (2010) Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342. J Clin Oncol 28:4747-54
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010) Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol 28:1247-53
Gitlitz, Barbara J; Moon, James; Glisson, Bonnie S et al. (2010) Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial. J Thorac Oncol 5:1835-40

Showing the most recent 10 out of 63 publications